US 6,713,448 B2Granted

Substantially pure glycopeptide antibiotics AC-98-1; AC-98-2; AC-98-3; AC-98-4 and AC-98-5

AssigneeWyeth Holdings Corporation

InventorsGuy Thomas Carter, Haiyin He

Life of this patent

Estimating the term…

Abstract

The invention provides new substantially pure antibiotics designated AC-98-1, AC-98-2, AC-98-3, AC-98-4 and AC-98-5 derived from the microorganism Streptomyces hygroscopicus.

Claims4

Dependent claims

A substantially pure compound having the structure

or pharmaceutically acceptable salts thereof.

Dependencies are inferred from the claim text.

Facts

Application: 10/132,012Filed 25 Apr 2002 · us provisional application
Priority: 25 Apr 2001
Published: US 2003/0054508 A120 Mar 2003
Granted: 30 Mar 2004
Term ends: Not estimatedThe source records don’t support an estimate.

Classification10 codes

C07H 15/203
Carbocyclic rings: monocyclic carbocyclic rings other than cyclohexane rings; Bicyclic carbocyclic ring systems
A61K 31/395
Heterocyclic compounds: having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
C07H 19/04
Sharing nitrogen: heterocyclic radicals containing only nitrogen atoms as ring hetero atom
C07K 9/008
The peptide sequence being part of a ring structure: directly attached to a hetero atom of the saccharide radical, e.g. actaplanin, avoparcin,…

Family

Application60/286,396Us provisional application · filed 25 Apr 2001
Application60/286,244Us provisional application · filed 25 Apr 2001
Application60/286,249Us provisional application · filed 25 Apr 2001
US 2003/0054508 A1Pre-grant publication · published 20 Mar 2003
US 6,713,448 B2This patent

From the US filing history. Foreign family members aren’t listed.

Timeline

Citations

Open elsewhere

patentgrep

Loading patent…

patentgrepSearch patents

Back to results